Search Results - Geoffrey R. Oxnard

Refine Results
  1. 1
    New Targetable Oncogenes in Non–Small-Cell Lung Cancer

    New Targetable Oncogenes in Non–Small-Cell Lung Cancer by Geoffrey R. Oxnard, Adam F. Binder, Pasi A. Jänne

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer

    Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer by Geoffrey R. Oxnard, Cloud P. Paweletz, Lynette M. Sholl

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review

    Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review by Adrian G. Sacher, Kimberly M. Komatsubara, Geoffrey R. Oxnard

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Circulating tumor DNA analysis in the era of precision oncology

    Circulating tumor DNA analysis in the era of precision oncology by Rabih Said, Nicolas Guibert, Geoffrey R. Oxnard, Apostolia M. Tsimberidou

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer

    New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer by Geoffrey R. Oxnard, Maria E. Arcila, Juliann Chmielecki, Marc Ladanyi, Vincent A. Miller, William Pao

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Clinical Implications of Variant ALK FISH Rearrangement Patterns

    Clinical Implications of Variant ALK FISH Rearrangement Patterns by Xin Gao, Lynette M. Sholl, Mizuki Nishino, Jennifer Heng, Pasi A. Jänne, Geoffrey R. Oxnard

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation

    Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation by Russell W. Jenkins, Geoffrey R. Oxnard, Sheryl K. Elkin, Elroy Sullivan, Jennifer Carter, David A. Barbie

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib

    Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib by Julia Rotow, Jessica Lee, Russell W. Madison, Geoffrey R. Oxnard, Pasi A. Jänne, Alexa B. Schrock

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Cl... by Jamie E. Chaft, Geoffrey R. Oxnard, Camelia S. Sima, Mark G. Kris, Vincent A. Miller, Gregory J. Riely

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer

    Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer by Adrian G. Sacher, Suzanne E. Dahlberg, Jennifer Heng, Stacy L. Mach, Pasi A. Jänne, Geoffrey R. Oxnard

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

    Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions by Michael L. Cheng, Eirini Pectasides, Glenn J. Hanna, Heather A. Parsons, Atish D. Choudhury, Geoffrey R. Oxnard

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism

    Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism by Atul B. Shinagare, Yuka Okajima, Geoffrey R. Oxnard, Pamela J. DiPiro, Bruce E. Johnson, Hiroto Hatabu, Mizuki Nishino

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping

    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping by Geoffrey R. Oxnard, Vincent A. Miller, Mark E. Robson, Christopher G. Azzoli, William Pao, Marc Ladanyi, Maria E. Arcila

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

    Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors by Sarah B. Goldberg, Geoffrey R. Oxnard, Subba R. Digumarthy, Alona Muzikansky, David M. Jackman, Inga T. Lennes, Lecia V. Sequist

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

    Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC by Hugo J.W.L. Aerts, Patrick Großmann, Yongqiang Tan, Geoffrey R. Oxnard, Naiyer A. Rizvi, Lawrence H. Schwartz, Binsheng Zhao

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

    Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA by Julianna Supplee, Marina S.D. Milan, Lee P. Lim, Kristy Potts, Lynette M. Sholl, Geoffrey R. Oxnard, Cloud P. Paweletz

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types

    Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types by Jake G Maule, Lani K Clinton, Ryon P. Graf, Jinpeng Xiao, Geoffrey R. Oxnard, Jeffrey S. Ross, Richard S.P. Huang

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression

    When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression by Geoffrey R. Oxnard, Michael J. Morris, F. Stephen Hodi, Laurence H. Baker, Mark G. Kris, Alan P. Venook, Lawrence H. Schwartz

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer

    "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer by Christian Grommes, Geoffrey R. Oxnard, Mark G. Kris, V.A. Miller, William Pao, Andrei I. Holodny, Jennifer Clarke, Andrew B. Lassman

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies

    Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies by Jason J. Luke, Geoffrey R. Oxnard, Cloud P. Paweletz, D. Ross Camidge, John V. Heymach, David B. Solit, Bruce E. Johnson

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: